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Abstract In cells, only properly folded procollagen trimers are
secreted from the endoplasmic reticulum (ER), while improperly
folded abnormal procollagens are retained within the ER.
Ascorbic acid is a co-factor in procollagen hydroxylation, which
in turn is required for trimer formation. We examined chaperone
proteins which bound to procollagen in the absence of ascorbic
acid, a model which mimics the human disease scurvy at the
cellular level. We found that both prolyl 4-hydroxylase (P4-H)/
protein disulfide isomerase (PDI) and HSP47 bound to
procollagen in the absence of ascorbic acid. However, the
binding of PDI to procollagen decreased when HSP47 was co-
transfected, suggesting that HSP47 and PDI compete for
binding to procollagen. These data indicate that P4-H/PDI and
HSP47 have cooperative but distinct chaperone functions during
procollagen biosynthesis.
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1. Introduction
Procollagens are synthesized within the endoplasmic retic-
ulum (ER), and only properly folded procollagen trimers are
secreted from the cell, while improperly folded abnormal pro-
collagens are retained within the ER [20]. Recently, molecular
chaperones have been reported to play important roles in
quality control [1]. HSP47 is an ER-resident stress protein
which is thought to function as a molecular chaperone speci¢c
to procollagen biosynthesis [2,3]. Protein disul¢de isomerase
(PDI) is another ER-resident chaperone protein [4,5] which
has dual functions in procollagen biosynthesis. As well as
forming intra- and inter-chain disul¢de bonds in the pro- or
telopeptide regions of procollagen [6], PDI also functions as
the L subunit of prolyl 4-hydroxylase (P4-H), an essential
enzyme for procollagen biosynthesis [7,8]. Procollagen trimer
formation is dependent upon correct hydroxylation of proline
residues in the triple helical region. In addition, PDI has re-
cently been reported to carry out a chaperone function during
procollagen biosynthesis [9,10].
In this study, we focused on identi¢cation of chaperone
proteins responsible for the ER retention of abnormal procol-
lagen synthesized under pathophysiological conditions such as
ascorbate depletion. Ascorbic acid is a co-factor of P4-H, and
it is known that ascorbate de¢ciency causes the human disease
scurvy by secreting improperly folded procollagens caused by
hypohydroxylation of proline residues. In every cell line that
we have examined, the expression of HSP47 always parallels
that of collagen [2], so we could not separate the expression of
these two proteins. Therefore, taking advantage of the fact
that 293 cells do not produce any extracellular matrix proteins
and express neither collagens nor HSP47 [11,12], we have
transfected type III procollagen cDNA, with or without
HSP47 cDNA, into 293 cells in order to analyze the function
of HSP47 in quality control of procollagen synthesis.
2. Materials and methods
2.1. Antibodies
Rabbit antiserum against human/bovine type III collagen was pur-
chased from LSL (Japan) and puri¢ed antibody against human type
III collagen from Southern Biotechnology Associates, Inc. (USA).
The rabbit antiserum against mouse HSP47 has been described else-
where [13], and monoclonal antibody raised against HSP47 (SPA-470)
was purchased from StressGen (Canada). Rabbit IgG against PDI
was kindly provided by Dr. A. Yamamoto (Kansai Medical Univer-
sity, Japan). Mouse monoclonal antibodies against human P4-HK and
P4-HL were purchased from Fuji Chemical Co. (Japan). Rat mono-
clonal antibody against GRP94 (SPA-850) and rabbit polyclonal anti-
body against calnexin (SPA-860) were from StressGen, and rabbit
polyclonal antibody against calreticulin was purchased from A⁄nity
Bioreagents, Inc. (USA). Rat antiserum against mouse GRP78 was
raised by Dr. M. Satoh (Aichi Human Service Center, Japan), and
mouse monoclonal antibody against ERp72 was a kind gift from Dr.
S. Saga (Aichi Medical University, Japan).
2.2. Cell culture and drug treatment
Construction and cell culture of 293 cell lines expressing proK1(III)
and/or HSP47 were as previously described [12]. For experiments in
the presence of ascorbate, ascorbic acid phosphate was added to the
culture medium at least 16 h before cell harvest [12]. K,KP-Dipyridyl
was added to culture medium containing ascorbate 4 h before meta-
bolic labeling, and was present during the labeling period, at a ¢nal
concentration of 0.3 mM.
2.3. Western blotting, metabolic labeling and immunoprecipitation
Cell lysate (10 Wg) was separated by SDS-PAGE, and immunoblot-
ting using speci¢c antibodies was performed as described previously
[12]. Metabolic labeling, chemical cross-linking and immunoprecipita-
tion procedures were carried out as described previously [12]. To label
both ER-resident and secretory proteins e⁄ciently, cells were meta-
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bolically labeled for 14 h with [35S]methionine (EXPRE35S35S, Du-
Pont-NEN) in the presence of 6 mg/l methionine, chased for 2 h in
DMEM containing excess methionine, then labeled again for 1.5 h
with [35S]methionine in medium lacking methionine [14].
2.4. In vitro translation and translocation using semipermeabilized cells
In vitro translation and translocation was performed using in vitro
transcribed bovine type X procollagen RNA, as described previously
[15]. Plasmid encoding bovine type X procollagen (pGEM-BX) was
kindly provided by Dr. N. Bulleid (University of Manchester, UK)
[16]. The EcoRI fragment of pGEM-BX was inverted and SP6 RNA
polymerase was used to transcribe RNA in vitro. 293 cells and
293+HSP47 cells (the latter being 293 cells stably transfected with
mouse HSP47) were treated with 30 Wg/ml digitonin to obtain semi-
permeabilized cells [15]. RNA was translated in rabbit reticulocyte
Fig. 1. Western blot analysis using antibodies against ER chaperone
proteins and type III collagen. 293 cells, 293 cells stably transfected
with proK1(III) chain (293+K1(III)), with mouse HSP47 (293+
HSP47) or with both proK1(III) chain and mouse HSP47 (293+
K1(III)+HSP47) and RD cells were cultured in the absence of ascor-
bate. Cells were lysed in a bu¡er containing 1% NP-40, and 10 Wg
of soluble fraction was resolved by SDS-PAGE. After blotting to a
nitrocellulose membrane and probing with antibodies against the in-
dicated proteins, immunoreactive bands were detected by enhanced
chemiluminescence (Amersham).
C
Fig. 2. Coprecipitation of type III procollagen with PDI. Cells were cultured in the presence (Asc+) or absence (Asc3) of ascorbate. Metabolic
labeling was performed for 14 h with [35S]methionine and chased in normal growth medium for 2 h, then labeled again for 1.5 h with
[35S]methionine. Cells were lysed in a bu¡er containing 1% NP-40 without pre-treatment (A), or after addition of the cross-linking reagent DSP
(B). Immunoprecipitation was performed using speci¢c antibodies against PDI (lanes 1^6) or against type III collagen (lanes 7^12). The posi-
tions of molecular mass markers (200, 117, 75 and 42.9 kDa) are shown in lane M. Arrowheads indicate PDI, and arrows indicate the K sub-
unit of P4-H (see Fig. 4). Brackets denote the positions of proK1(III) chains. Asterisks indicate a collagenous protein which was expressed in
RD cells and was recognized by polyclonal antibody raised against type III collagen (LSL Co.). This band was considered to represent type IV
procollagen (see Section 3).
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lysates (FlexiLysate, Promega) at 30‡C. Proteinase K digestion
(200 Wg/ml) was carried out on ice for 30 min, and terminated by
adding phenylmethylsulfonyl £uoride to a ¢nal concentration of
2 mg/ml and boiling for 2 min in Laemmli’s sample bu¡er [17]. For
pepsin digestion, semipermeabilized cells were pelleted by centrifuga-
tion at 13 000Ug for 5 min, resuspended in 20 Wl of 0.5 M acetic acid
containing 1% Triton X-100, and then digested with 100 Wg/ml pepsin
for 14 h at 4‡C. Digestion was terminated by adding NaOH to neu-
tralize the pH and boiling for 2 min in Laemmli’s sample bu¡er [16].
3. Results
3.1. Expression of ER chaperone proteins
We ¢rst examined the expression levels of several ER chap-
erone proteins in the cell lines used in this study by Western
blot analysis with speci¢c antibodies (Fig. 1). These experi-
ments were performed in the absence of ascorbate to detect
the intracellular accumulation of type III procollagen, because
procollagens are rapidly secreted from the cell in the presence
of ascorbate [12]. The RD cell line (ATCC CCL 136) was
established from a human rhabdomyosarcoma, and is known
to secrete normal type III collagen. We observed some di¡er-
ences in the expression levels of ER chaperone proteins be-
tween RD cells and 293 cells, but no signi¢cant di¡erences
among 293 cells and cell lines derived from 293 cells. It should
be noted that HSP47 was barely detectable in 293 cells. No
change was detected in the expression level of any of these ER
chaperone proteins when the cells were cultured in the pres-
ence of ascorbate (data not shown). This suggests that stable
overexpression of HSP47 or type III procollagen did not alter
the levels of other ER chaperone proteins expressed in 293 cell
lines.
3.2. Coprecipitation of type III procollagen with PDI
When cells are cultured in the absence of ascorbic acid,
hydroxylation of procollagens is inhibited, and the resulting
hypohydroxylated procollagens are retained within the ER
because they cannot form properly folded helical trimers.
We examined the interaction of type III procollagen with
ER chaperone proteins by immunoprecipitation following cul-
ture in the presence or absence of ascorbic acid. Among the
ER chaperone proteins examined (PDI, GRP94, GRP78, cal-
nexin and calreticulin), clear coprecipitation of type III pro-
collagen was observed only when polyclonal antibody against
PDI was used in the absence of ascorbic acid (Fig. 2A). Co-
precipitation of proK1(III) chain was undetectable in ascor-
bate-treated cells (Fig. 2A). These results were observed in
both RD cells and 293 cells transfected with type III procol-
lagen. The cell lysates contained comparable amounts of ra-
diolabeled proK1(III) chain under the experimental conditions
used (Fig. 2A). The di¡erent electrophoretic mobilities of the
proK1(III) chain in the presence or absence of ascorbate re-
£ect the di¡erences in hydroxylation of the procollagen chain.
Transient association of PDI with the proK1(III) chain was
examined in the presence of ascorbate by treatment with a
chemical cross-linking reagent (DSP) prior to cell lysis. Co-
precipitation of proK1(III) chain with PDI was detected at
low but reproducible levels in cell lysates treated with ascor-
bate (Fig. 2B). It is noteworthy that in 293+K1(III)+HSP47
cells, smaller amounts of proK1(III) chain were coprecipitated
by anti-PDI antibody than in 293+K1(III) cells (Fig. 2B).
The slowly migrating band which was precipitated by anti-
body against type III collagen in RD cells (indicated by an
asterisk in Fig. 2) was shown to be type IV procollagen (data
not shown).
3.3. Coprecipitation of type III procollagen with PDI and
HSP47 in the absence of ascorbate
We have previously reported that HSP47 binds to type I or
III procollagens both in the absence and in the presence of
ascorbic acid [12,18] (see also Fig. 5). In this study, we com-
pared the binding of type III procollagen to PDI and HSP47
in the absence of ascorbate (Fig. 3). In 293 cells stably trans-
fected with both type III procollagen and HSP47
(293+K1(III)+HSP47 cells), coprecipitation of K1(III) chain
was detected using either antibody against PDI or antibody
against HSP47 (Fig. 3). In 293 cells transfected only with
proK1(III) chain, HSP47 was expressed at very low levels
and anti-HSP47 antibody did not coprecipitate detectable
amounts of proK1(III) chain (Fig. 3). The amount of pro-
K1(III) chain coprecipitated by anti-PDI antibody was much
smaller in 293+K1(III)+HSP47 cells than in 293+K1(III) cells
(Fig. 3, compare lanes 2 and 5). This suggests that the binding
of HSP47 and PDI to procollagen is competitive in the ab-
Fig. 3. Coprecipitation of type III procollagen with PDI and HSP47
in the absence of ascorbate. Cells were cultured without ascorbate,
and metabolically labeled with [35S]methionine as in Fig. 2. After
treatment of the cells with the cross-linking reagent DSP, cell lysates
were prepared and immunoprecipitation was performed. Immune
complexes were analyzed by 8% SDS-PAGE. An arrow indicates
PDI, and open triangles denote HSP47. ProK1(III) collagen chain is
marked by an arrowhead. Film was exposed for shorter periods (ap-
prox. 1/3) when anti-HSP47 antibody was used.
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sence of ascorbate. In other words, from the point of view of
chaperone activity, both PDI and HSP47 appear to be in-
volved in retention of improperly folded procollagens within
the ER.
3.4. PDI in the P4-H tetramer binds to procollagen
Because PDI is the L-subunit of P4-H (which is an K2L2
heterotetramer), we examined whether PDI in the P4-H tet-
ramer could bind to procollagen in the absence of ascorbate.
The results of immunoprecipitation using monoclonal anti-
bodies against P4-HL and P4-HK are shown in Fig. 4. In
the absence of ascorbate, coprecipitation of proK1(III) colla-
gen chain was detected using both antibodies. A band of
slightly lower mobility which coprecipitated with PDI/P4-HL
was considered to be the K subunit of P4-H, judging by its
molecular size. Thus, in the absence of ascorbate, PDI was
shown to bind to procollagen, at least in part, as the L subunit
of P4-H. However, it is di⁄cult to discriminate between PDI/
P4-HL binding to procollagen in vivo as a homodimer (PDI)
and as a heterotetramer (P4-H). It is of note that almost equal
amounts of PDI/P4-HL and P4-HK were detected in 293 cells,
which do not express procollagens (Fig. 4). This is consistent
with the observation that 293 cells have P4-H activity com-
parable to that of RD cells (Hosokawa et al., unpublished
observation; Ku«hn et al., manuscript submitted).
Because P4-H is known to bind to procollagen in the ER
when cells are treated with K,KP-dipyridyl [19], we compared
the binding of PDI/P4-HL to procollagen in the absence of
ascorbate and in the presence of K,KP-dipyridyl. K,KP-Dipyr-
idyl chelates ferrous ions, one of the co-factors of P4-H, and
cells treated with this drug synthesize unhydroxylated procol-
lagen. Cells cultured with or without ascorbate, or treated
with K,KP-dipyridyl, were lysed without cross-linking treat-
ment and immunoprecipitation was performed (Fig. 5). In
cells cultured without ascorbic acid or treated with K,KP-di-
pyridyl, coprecipitation of type III procollagen was detected
by antibodies against P4-HK or PDI/P4-HL. Under the con-
ditions employed, the cell lysates contained almost equal
amounts of radiolabeled procollagens. The di¡erent electro-
phoretic mobilities of proK1(III) collagen chains re£ect the
degree of hydroxylation of proline residues: partial hydroxyl-
ation occurred in the absence of ascorbate, while hydroxyla-
tion was inhibited almost completely by the addition of K,KP-
dipyridyl. We detected more coprecipitated proK1(III) chain
when cells were treated with the chemical cross-linking re-
agent DSP prior to lysis (data not shown). While HSP47
bound to procollagen under all the conditions examined, it
should be noted that more procollagen bound to HSP47
when the cells were treated with K,KP-dipyridyl, which is con-
sistent with our previous reports [14,18]. These results suggest
that under conditions which inhibit procollagen hydroxylation
(ascorbate de¢ciency or K,KP-dipyridyl treatment), the result-
ing improperly folded procollagens are retained within the ER
through interaction with PDI/P4-H and HSP47.
Fig. 4. Immunoprecipitation using antibodies against PDI (P4-HL) and P4-HK. Cells were metabolically labeled with [35S]methionine for 3 h,
and immunoprecipitation was performed as described in Fig. 2. The position of PDI/P4-HL is indicated by arrows. Film was exposed two-fold
longer when anti-P4-HK antibody was used (lanes 11^20).
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3.5. In vitro translation-translocation of type X procollagen
using semipermeabilized cells
We next looked for di¡erences in procollagen synthesis in
the presence or absence of HSP47, using an in vitro trans-
lation-translocation system in reticulocyte lysates. We pre-
pared semipermeabilized cells using digitonin, and synthesized
bovine type X procollagen RNA by in vitro transcription with
SP6 RNA polymerase. We used type X collagen as a model
for procollagen trimer formation, because the translation-
translocation e⁄ciency was very poor when long procollagen
RNAs such as proK1(III) or proK1(I) were used. Parental 293
cells and 293 cells stably transfected with mouse HSP47
(293+HSP47 cells) were used to compare the e¡ect of
HSP47. The translation and translocation e⁄ciencies were al-
most identical in these two cell lines (data not shown). When
the e⁄ciency of triple helix formation was examined by pepsin
digestion, pepsin-resistant type X procollagen trimer was de-
tected in both cell lines, and there was no di¡erence in the
time course of trimer formation between the cell lines (Fig. 6).
We also examined earlier time points (15 and 30 min), but
could not detect any di¡erence between the parental and
HSP47-transfected cell lines (data not shown). These results
suggest that HSP47 does not facilitate trimer formation of
type X procollagen.
4. Discussion
We examined the involvement of ER chaperone proteins in
the retention of improperly folded type III procollagen within
the ER under conditions of ascorbate de¢ciency. We found
that both PDI and HSP47 bound to procollagen in the ab-
sence of ascorbic acid, and that PDI was the main chaperone
protein which bound to the procollagen chain in cells lacking
HSP47 (Figs. 2 and 3). The observation that type III procol-
lagen was coprecipitated by antibody against P4-HK (Fig. 4)
suggests that PDI bound to procollagen, at least in part, in
the form of P4-H. P4-H has been reported to bind to unhy-
droxylated procollagen treated with K,KP-dipyridyl [19]. The
binding of the K and L subunits of P4-H to type III procolla-
gen was similar in cells treated with K,KP-dipyridyl and cells
cultured without ascorbate (Fig. 5).
We could not detect binding of type III procollagen to BiP/
GRP78 in the absence of ascorbate (data not shown). This is
consistent with the observation that in cells from osteogenesis
imperfecta patients, type I procollagen with a point mutation
in the C-propeptide region binds to BiP/GRP78, while procol-
lagen with a point mutation in the triple helical region binds
to PDI/P4-H but not to BiP/GRP78 [21^23]. From the point
of view of quality control, BiP/GRP78 may be mainly in-
Fig. 5. Binding of type III procollagen to P4-H and HSP47 in cells treated with K,KP-dipyridyl. Cells were cultured in the absence or presence
of ascorbate, or treated with K,KP-dipyridyl. After metabolic labeling for 3 h, cells were lysed without cross-linker, and immunoprecipitation
was performed.
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volved in regulating abnormality in the C-propeptide region,
while PDI/P4-H monitors the triple helical region.
For this study, we used 293 cell lines which were stably
transfected with the proK1(III) collagen chain, with or with-
out HSP47. Using these cell lines, we could separate the ex-
pression of procollagens and HSP47. A transfection-based
model was necessary because, among the cell lines we have
examined, all vertebrate cell lines which express some type of
collagen also express HSP47 at the same time [2,12]. Our
results suggest that the binding of HSP47 and PDI/P4-H to
procollagen in the absence of ascorbate is competitive, and
that in cells lacking HSP47, PDI/P4-H is the main chaperone
protein that binds to hypohydroxylated procollagen (Fig. 3).
The binding of PDI/P4-H and HSP47 to procollagen was
di¡erent in the presence of ascorbate. Although the binding
of PDI/P4-H to procollagen was transient in the presence of
ascorbate, HSP47 bound stably to procollagen either in the
presence or absence of ascorbate (Figs. 2 and 4). Several
studies, including expression of collagens in yeast [24], insect
cells [25,26] and 293 cells [12], suggest that it is possible for
various cells to synthesize and secrete ‘roughly normal’ colla-
gen trimer without HSP47. In the present study, HSP47 was
not necessary for procollagen trimer formation in an in vitro
translation-translocation system (Fig. 6). In contrast, we have
shown that disruption of the HSP47 gene was embryonic le-
thal in mice as a result of abnormal procollagen processing,
suggesting that HSP47 plays an essential role in normal pro-
collagen biosynthesis in vertebrates (Nagai et al., manuscript
submitted). Although the precise mechanism by which HSP47
acts as a molecular chaperone remains to be clari¢ed, these
data suggest that HSP47 is essential for procollagen biosyn-
thesis as a molecular chaperone in addition to the chaperone
activity of PDI/P4-H.
While we were preparing this article, N. Bulleid’s group
published a manuscript demonstrating that procollagen is re-
tained within the ER in the absence of ascorbate by P4-H,
using a ‘minicollagen’ which lacks most of the triple helical
region of proK1(III) [27]. While they showed that HSP47 did
not bind to the ‘minicollagen’, we could clearly show the bind-
ing of HSP47 with type III procollagen in the absence or
presence of ascorbic acid. This discrepancy is probably due
to the the fact that the Bulleid group used ‘minicollagen’ for
their experiments, whereas we used natural full-length procol-
lagen. Further experiments will be needed to clarify the func-
tion of HSP47.
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